Heidenheim, March 25, 2022. Health care company HARTMANN is announcing price increases in most product categories and markets to compensate the significantly higher costs for raw material, energy and freight that have been hitting the markets for several months.
"We are facing historically high costs for raw material, energy and freight. We do not expect these costs to decrease in the near term. Our goal is to assure ability to supply. Therefore, price increases play an essential role to compensate for the higher costs and assure continued supply ability. We have taken a wide range of productivity actions to improve our efficiency and reduce costs to help offset the strong inflationary challenges and subsequent pricing. We are confident that appropriate measures will ensure our ability to continue to provide the products and services our customers rely on", states the HARTMANN Management Board.
About HARTMANN GROUP
The HARTMANN GROUP is one of the leading European providers of professional medical and care products and associated services. Every day, healthcare professionals and patients rely on HARTMANN brands in the segments of Incontinence Management (e. g. MoliCare®), Wound Care (e. g. Zetuvit®) and Infection Management (e. g. Sterillium®). This is expressed in our brand promise of "Helps. Cares. Protects." In 2021, the HARTMANN GROUP reported Group sales of EUR 2.3 billion. Founded in 1818, the company sells its products and solutions in 130 countries around the world. For the future, the HARTMANN GROUP is currently implementing its strategic Transformation Program with its high-performance, customer-oriented and passionate team.
For the latest information on HARTMANN, follow @HARTMANN_GROUP on Twitter.
To learn more about the HARTMANN GROUP, visit: https://hartmann.info/.
Paul Hartmann AG published this content on 25 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 March 2022 14:46:03 UTC.
Paul Hartmann AG is a Germany-based holding company that is principally engaged in the field of medical and healthcare products. The Company operates through four segments, namely Wound Management, Incontinence Management, Infection Management and Other Group Activities. The Wound Management segment comprises wound dressings, as well as products for compression treatment, immobilization, First Aid and diagnostic devices. The Incontinence Management segment includes absorbent products worn close to the body for incontinence hygiene, such as under pads for patients as well as patient hygiene products and medical skin care. The Infection Management segment covers a range of custom procedure trays, surgical draping systems, surgical clothing, and surgical and examination gloves as well as the disinfection assortment. The Other Group Activities includes activities in cotton-wool products, feminine hygiene, baby care, medical consumer goods and pharmaceutical products, among others.
PAUL HARTMANN AG 
